De novo Membranous Glomerulopathy in a Renal Transplant Patient Treated with FK 506. The First Reported Case

We describe a case of de novo membranous glomerulopathy in the renal allograft of a diabetic patient, treated with the newer immunosuppressive agent FK 506. Twenty-two months later this patient developed nephrotic range proteinuria.